ARTICLE | Deals
Embrace the competition from China, says Maraganore
U.S. biotechs need to rise to the challenge and learn from their competitors
February 14, 2025 9:07 PM UTC
The rising competition from China is to be welcomed not feared, says John Maraganore, who argues the innovation will push biotechs globally to greater heights and provide a net positive for patients and the biopharma ecosystem.
In a fireside chat with BioCentury at the BIO CEO & Investor Forum in New York on Feb. 11, Maraganore, the former and longtime CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) who is now chairman of City Therapeutics Inc., took a strong stance to encourage openness to this new source of competition...